Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Sutro Biopharma Inc
NASDAQ:STRO
Sutro Biopharma Inc
NASDAQ:STRO
Price:
9.11
USD
0.11%
Market Closed
Market Cap:
$151m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
A
|
American Coastal Insurance Corp
F:0UI
|
US |
|
F
|
Federated Hermes Inc
F:3KC
|
US |
|
Banco Santander SA
F:BSDK
|
ES |
|
L
|
LSI Industries Inc
F:LS2
|
US |
Wall St Price Targets
STRO Price Forecast
Based on 15 analysts
Based on 15 analysts
+460% Upside
from
$9.11
today
Sutro Biopharma Inc (STRO)’s 12-month stock price forecast through November 2027 has a consensus target of $51, implying 460% upside. The forecast is based on price targets from 15 Wall Street analysts.
STRO Analyst Rating
Based on 14 analysts
Based on 14 analysts
Analysts rate STRO Strong buy, with 13 of 14 recommending Buy or Strong buy.
Sutro Biopharma Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is STRO's stock price target?
Price Target
51
USD
51
USD
According to Wall Street analysts, the average 1-year price target for STRO is 51 USD with a low forecast of 10.1 USD and a high forecast of 64.05 USD.
What is the Revenue forecast for Sutro Biopharma Inc?
Projected CAGR
20%
20%
Over the last 8 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 20%.
